Table Of Content

Subject Index to Volume 53 A L-Amino acid decarboxylase deficiency nical and ther a oDse rvations i iromatic L amino acid Acetazolamide decarbox\ iS€ Swoboda et al| 1999:53 1205 Amnesia pertuslor ind lagnetic resonance Acetylcholine nsient al etter piv) 1999-5 postencephalit after bilateral mpora 1999:53 Ado. lescents Amputatio: n eta 1999 tei ue at : imputat ion (Roricht ‘ et al) 1999:5 on-ment 1999:5 Amygdala disorders MRI vol In non-mentally r etarded al) 1999:53 21 45 iropathy caused ] DY Adrenergic receptors ni et al 1999 93:05 / iopathy with unilateral hemorrhages, mass effect ancement (Morton-Bours et al) 1999:53:233 remorrnages: potential marker of progression in MacDe 1 angiopati Greenberg et al 1999:53:1135 Geriatric population Mascalchi et vid1o9s9 9-5 ind i siderosis of the ( NS a are Fe.a9 Amyotrophic later sclerosis ; poy orithm for ALS « Swash) 1999;53:S58 istering of ALS pa nts trai it \ 1e to the occurrence of the L84F SOD1 1999:53:1064 I 1999-:53:1665 Aldos« reductas¢ ALS: a Un ited State perspective (Deng rican perspective Alzheimer’s disease 1 rirst syn 5) 1999-53:S1 ip discussior 1999-53:S20 ALS daiscusslo! 2 1999:53:S35 ALS | u 3sion 1999:53:S40 ALS: gr up' discussion 4 1999:53:S55 ALS group d scussion 5 1999:53:S67 wirus RNA sequences lt 53-16 il) 1999 1999:53:S26 idolp! Brooks excess 1999:5 Bleecker et al 1999:°5 ALS De sport et \ , nead 1999 53-999 yrospectiv preference ul al tre atment choices in ALS Albert 1999:53 er percutaneous endos oOpic gastrost‘ omy 1999:53:1123 simplify ng ig theti ippr yach 1 \ )? trong 1999:53:S31 SODI gene mut: slowly progressing familial ALS Penco et a tongue ind limb iteral scl|e rosis (Sander et Amantadine 1999 53:1889 arly maintaining optimal possible (Brook 1999:53:S43 August issue 4145-660; September 11 is 1e, pp 661—896 September 22 issue, p pp 897 1162 ipplement 2 S1-S100; September Supplement 3 pp| S1-S 53: October 12 issue, pp 1163-1378; pp S1 nber issue pp 1613 1898: November, S ipplement 5, pp S1-S72 December issue, December (1 of 1) 1999 Subject Index to Volume 53 A L-Amino acid decarboxylase deficiency nical and ther a oDse rvations i iromatic L amino acid Acetazolamide decarbox\ iS€ Swoboda et al| 1999:53 1205 Amnesia pertuslor ind lagnetic resonance Acetylcholine nsient al etter piv) 1999-5 postencephalit after bilateral mpora 1999:53 Ado. lescents Amputatio: n eta 1999 tei ue at : imputat ion (Roricht ‘ et al) 1999:5 on-ment 1999:5 Amygdala disorders MRI vol In non-mentally r etarded al) 1999:53 21 45 iropathy caused ] DY Adrenergic receptors ni et al 1999 93:05 / iopathy with unilateral hemorrhages, mass effect ancement (Morton-Bours et al) 1999:53:233 remorrnages: potential marker of progression in MacDe 1 angiopati Greenberg et al 1999:53:1135 Geriatric population Mascalchi et vid1o9s9 9-5 ind i siderosis of the ( NS a are Fe.a9 Amyotrophic later sclerosis ; poy orithm for ALS « Swash) 1999;53:S58 istering of ALS pa nts trai it \ 1e to the occurrence of the L84F SOD1 1999:53:1064 I 1999-:53:1665 Aldos« reductas¢ ALS: a Un ited State perspective (Deng rican perspective Alzheimer’s disease 1 rirst syn 5) 1999-53:S1 ip discussior 1999-53:S20 ALS daiscusslo! 2 1999:53:S35 ALS | u 3sion 1999:53:S40 ALS: gr up' discussion 4 1999:53:S55 ALS group d scussion 5 1999:53:S67 wirus RNA sequences lt 53-16 il) 1999 1999:53:S26 idolp! Brooks excess 1999:5 Bleecker et al 1999:°5 ALS De sport et \ , nead 1999 53-999 yrospectiv preference ul al tre atment choices in ALS Albert 1999:53 er percutaneous endos oOpic gastrost‘ omy 1999:53:1123 simplify ng ig theti ippr yach 1 \ )? trong 1999:53:S31 SODI gene mut: slowly progressing familial ALS Penco et a tongue ind limb iteral scl|e rosis (Sander et Amantadine 1999 53:1889 arly maintaining optimal possible (Brook 1999:53:S43 August issue 4145-660; September 11 is 1e, pp 661—896 September 22 issue, p pp 897 1162 ipplement 2 S1-S100; September Supplement 3 pp| S1-S 53: October 12 issue, pp 1163-1378; pp S1 nber issue pp 1613 1898: November, S ipplement 5, pp S1-S72 December issue, December (1 of 1) 1999 Analgesics effect of simple analg« e out of jargon: a neurolinguistic and computational Wang et al) 1999 nt of jargon aphasia (Hillis et al) 1999;53:1813 Aneurysms protein E aneurysms in relative t and -491 polymorphisms are not associated with MS (Ferri frequency and risk f 199;53:888 Group) 1999;53:982 unt predicts age when prevalence of AD increases, then long-term follow-uy the Cache County Study (Breitner et al) 1999;53:321 internal carotid art type as a risk factor for ischemic cerebrovascular disease: a Angiitis alysis (McCarron et al) 1999;53:1308 brain biopsy in prim ype in relation to AD and cholesterol: a study of 2,326 et al) 1999:53:858 e adults (Liu et al) 1999;53:962 Angiopathy issociated with less frontal and more medial temporal cerebral amyloid ang n AD (Geroldi et al) 1999;53:1825 and meningeal enha promoter polymorphism is a risk factor for late-onset Anorgasmia ner’s disease (Casadei et al) 1999;53:1888 gabapentin-induced \POE on dementia is not through atherosclerosis: The Anosognosia lam Study (Slooter et al) 1999;53:1593 pontine anosognosia fo! lfaction as a marker for cognitive decline: interaction with 647 Antibodies. See also Monoclonal antibs protein E ¢€4 status (Borenstein Graves et al) 1999;53:1480 \POE genotype on familial aggregation of AD in an urban antibodies to prothroml tion (Devi et al) 1999;53:789 Kalashnikova et antiphosphatidyl serine ral hemorrhage outcome: apolipoprotein E genotype, ischemic stroke (T ma, and edema volumes (McCarron et al) 1999;53:2176 effect of anti-a4 inte te treatment of AD: influence of apolipoprotein E genotype (Tubridy et al) 1999 et al) 1999;53:2010 Guillain-Barré synd emory decline in cognitively normal apolipoprotein E-«4 1999;53:2122 ites (Caselli et al) 1999;53:201 humoral respons¢ molecular mimic (Br death of the oligodendrocyte a critical event in the inverse correlation of HT! nesis of multiple sclerosis? (Rodriguez and Lucchinetti synthesis of HTLV-1 1999:53:1615 1999:53:1335 marginally improve sion-body myositis muscle fibers do not accumulate in multifocal can be innervated (McFerrin et al) 1999;53:2184 myasthenia, thymon neuromus¢ ralization: relationship of language and ideomotor praxis neonatal Guillair et al) 1999;53:2028 from mother irospasm, and apraxia of eyelid opening secondary to novel antine hemorrhage (Verghese et al) 1999:53:652 re clerosis to test or not clerosis and hemodynamic disturbance may induce Anticipation sis (Yamauchi et al) 1999;53:1833 preliminary ev Jakob disea MS lack beta-2 adrenergic receptors (De Keyser et al repeats may not be 1628 Conneally Edi Antiepileptic drugs tations: hemiplegic migraine, episodic ataxia type 2, and allergies to multiple lournier-Lasserve) (Editorial) 1999;53:3 and SSA (Attar xia associated with subclinical celiac disease responding brief AED withd free diet (Pellecchia et al) 1999;53:1606 53:1736 MRI findings in spinocerebellai ataxia type 5 (Stevanin et cost-elfectiv 331355 epilepsy irments in patients with congenital nonprogressive 1999:53:657 itaxia (Steinlin et al) 1999;53:966 guideline n spinocerebellar ataxia type 7 (Morrow et al Wilkins 1999:53:244 positive and neg ndrome characterized by wild arm ataxia (Currier and patients w 999;53:1608 53:853 study in autosomal dominant cerebellar ataxia, serum leptin ¢ ind narcolepsy (Melberg et al) 1999;53:2190 therapy \1A gene mutation in acetazolamide-responsive familial vigabatrin, a g migraine and ataxia (Battistini et al) 1999;53:38 field defects GAAGGA repeat in the Friedrich gene: implications for Antioxidants radical reactions fror sis (Ohshima et al) 1999;53:1854 ferroxidase as ¢ e mutation in CACNAIA causes episodic ataxia and Editorial) 1999 4 Jen et al) 1999;53:34 Antiphosphatidy! serine antibodies lerosis antiphosphatidyl serins t s not implicated in association of APOE «4 with AD ischemic stroke 1999:53:236 Antiplatelet therapy POE on dementia is not through atherosclerosis: The antiplatelet therap Study (Slooter et al) 1999;53:1593 Albers and Tijs n of paraoxonase gene polymorphism with atherosclerosis antiplatelet therapy 1er’s disease (Sodeyama ct al) 1999;53:1146 4) 1999;53:S32 antiplatelet treatment of attention after cingulotomy (Cohen et al) 1999;53:819 stroke (Sivenius et is of defective attention in left unilateral neglect Antiretroviral therapy ymeo and Chokron) 1999;53:2023 highly active antiretro an population abnormalities ir e matter hyperintensities: three-year follow-up of the Antiseizure drugs. See Antiepileptic d Stroke Prevention Study (Schmidt et al) 1999;53:13: Anxiety disorders cluster headaches: assoc of amygdala and hippocampus in non-mentally retarded deficits (Jorge et idolescents and adults (Aylward et al) 1999;53:2145 December (1 of 1) 1999 NEUROLOGY 53 2219 Autoantibodies n injury; t t tl 1 te rair ation i gnitively intact individuals at high risk Smith et al) 1999 93:1391 if CYP2D genes in human brain and Axons £ . Woo et al 1999;53:1570 } | ' nati! ) na ition during working memory 1 month after mild traumatic IRI study (McAllister et al mic disturbance may induce 1) 1999:53:1833 B, Babinski reflex > acille-Calmette-Guerin i £ nyperaigee sia t nctic I V n et 53:548 mono alloon occlusion Re> ply)ly 19999090 -5 P é f ( rats ir tibiltoi steizyur e 1999:53:915 and heterotopia zure-induced brai 1999:53:619 ibolite Behavioral problems. Sec Psychiatric issues : caaal cd Biopterin normalities in 1 lemer hang et al) 1999:53 lept irospasn Blood pressure Hypertension; Hypotension Bolivia 1999:53:1698 ind Berna Reply) 1999;5 1109%9 9 ~ 119 ( Brain stimulation. S lranscranial magnetic stimulation er } tir t for the tre ment of essentitraemlo r Pp 1999:53:871 r thalamic 1999:53:1774 Borrelia burs lorferi Breast cancer nov yndrom¢ Botulinum toxin Bromocriptine }-vear rando Brumlik, Joe Joel Br C CACNAIA gene AC 1A y nigraine, episodic ata Editorial) 1999;53:3 sotulism imilies with familial hemiplegi migra 1999:53:26 new CACNAIA gene mutation in acetazolamide-responsive fa sgradykinin hemipleg l I rraine and ataxia (Battistini et al) 1999:53:: novel nonsense mutation in CACNAIA causes episodic ataxia and 1999-53 hemiples Jen et al) 1999:53:34 December (1 of 1) 1999 CADASIL ycle effects on cortical excitability (Smith et al) 1999;53 cerebrospinal fli indi \ Calcification mptoms restricted to proximal body parts in small cortical edema assoc.ated with cal retion (Kim) 1999;53:889 Patronas) 1999;53:77 al embolism Canadian population yurce of cerebral embolism in migraine with aura: a mortality in elderly ( nial Doppler study (Cheng) (Letter); (Anzola et al) (Reply) follow-up (Ostby t 19;53:2213 Cannabis ral lateralization suppression of pendular iteralization: relationship of language and ideomotor praxis with multiple scle I idor et al) 1999;53:2028 ‘apillary leak syndrome ral metabolism lethal capillary leak s ibatrin on cerebral blood flow and metabolism (Spanaki et interferon beta-1b 19:53:1518 carbamazepine study of cerebral glucose metabolism, MRI, and disability carbamazepine in co tients with MS (Blinkenberg et al) 1999;53:149 too often torgotter Ar? al veins 53:1170 icranial hypertension as the only sign of cerebral venous ‘arbidopa bosis (Biousse et al) 1999;53:1537 immediate-release and spinal fluid } year randor ed human herpesvirus 6 and 7 from spinal fluid and serum of ‘ardiovascular disease. S tiple sclerosis patients (Mirandola et al) 1999;53:1367 ‘arotid arteries ymeningeal gadolinium enhancement on cranial MRI acute isolated mono ) te symptomatic CSF leak (Mokri et al) 1999;53:402 dissection (L ta inal fluid findings in CADASIL (Dichgans et al) 1999; antithrombotic t1 fluid isoprostane shows oxidative stress in patients with r sclerosis (Greco et al) 1999;53:1876 of the al of tcome in pneumococcal meningitis correlates with CSF TOAST \di J hoic acid concentrations (Schneider et al) 1999;53:1584 carotid arteryd l ( SF prostaglandin E, levels in patients with probable AD 1999:53:1886 ntine et al) 1999;53:1495 long-term follow-up of rrelation of HTLV-1 viral load in CSF and intrathecal internal carotid a ; of HTLV-1 antibodies in TSP/HAM (Puccioni-Sohler et orthostatic limb shal 31335 1999;53:650 e metabolites in cerebrospinal fluid of patients with MS are carpal tunnel syndrome 1 to a clinical disease course (Svenningsson et al) 1999;53 assessment ol! irp ‘atalepsy f glutamate levels in the CSF of patients with HIV-1- catalepsy after strol : ted dementia complex (Espey et al) 1999;53:1144 ‘atamenial epilepsy ecificity, and stability of CSF-tau in AD in a community catamenial epilepsy patient sample (Andreasen et al) 1999;53:1488 epilepsy in women: t CSF neuron-specific enolase in patients with West e (Suzuki et al) 1999;53:1761 hormonal con rovascular disease. See Ischemic stroke; Stroke 93:538 im 1CNU dynamic impairment: methods of measurement and neoadjuvant | ! tion with stroke risk (Derdeyn et ai) (Views & Reviews aggre ve 51 ‘eliac disease lasmin cerebellar atax f the gene frequency of aceruloplasminemia in Japan to gluten-free dit et al) 1999;53:617 ‘erebellar ataxia lasmin deficiency increases advanced glycation end the brain (Tajima et al) 1999;53:619 ; from missing ceruloplasmin: the importance of a is an endogenous antioxidant (Graf and Noetzel 1999:53:446 Marie-Tooth neuropathy mpaction in Charcot-Marie-Tooth neuropathy type 1A with ‘erebellum t mutation of peripheral myelin protein-22 (Fabrizi et al cerebellar hen ri 846 reports (Chen et 1999 ralformations effect of hypervent iri I malformations: do clinical and radiologic features lisorders (Walker e? (Wetu a l) 1999;53:1271 superficial siderosis o . tumors (Kassubek et recessive juvenile parkinsonism in a Jewish Yemenite Cerebral blood flow red: mutation of Parkin gene (Nisipeanu et al) 1999;53:1602 effect of vigabatrir ( issues in pediatric epilepsy (Dunn and Austin) (Sept, suppl il) 1999 518 53:S96 reduced cerebral bl te childhood myositis: laboratory and clinical features proximal myot iy et al) 1999;53:2127 regional cerebral blood fl i-onset epilepsy with and without preceding febrile seizures bodies and AD h t al) 1999;53:1742 ‘erebral cortex nd imaging features of cortical malformations in childhood brief bursts of pulse st nter et al) 1999:53:715 cortical stimulation (1 rrelations of occipital epileptiform discharges in children clinical and imaging featur on et al) 1999;53:265 (Leventer et a i sum measurements in girls with Tourette syndrome cortical activation pa 1 tofsky et al) 1999;53:1345 saccades (Bodis-Wolln« ng institutional child abuse: a road too well traveled (Pe rcy) cortical excitability and 93:1617 (Brodtmann et al ) l Parkinson’s disease with REM sleep behavior disorder, immunoglobulin G and piness, and daytime REM onset (Rye et al) 1999;53:1868 cortex of patients sclerosis in children under 6 years of age (Ruggieri et al) 1999;53:699 »-53:47 mechanisms and clinical f complications of pediatric lung transplantation (Wong et al) Selden et al) 1999;53:131 1542 December (1 of 1) 1999 NEUROLOGY 53 2221 sonism link Complement 1999-5 I75 mmunoglobt ur nr nent immunoreactivity in the cerebral iologic ussen’s encephalitis (Whitney et al 1999:53:699 Confusional states psychosis and al « 1 t s (Li n ept, suppl 2 1999:53:S Consent f cerebrovascular diseases: a Academy of Neurology Ethics and 1999:53:9 Chinese population Corpus callosum corpus osu! Mostofs| Corrections lrome 1999;53:1612 ical twins 1999;53:246 Chlamydia pneumoniae ' f oT v I contril oO 1al in ‘H MRoSf t he Cholestero } PF ed t cs of5 3t:o1p1i6r2a mate bosis durin preg Choroid separa : ; lati Parkinson’s disease 1999 Chromosomes Corticiosb asal degeneration . ‘ Seciaiis soliverl presentation of ical-basal lionic 1999:53:1969 eonosed cor 1999-53:249 phy of the choroid ar hyperor ner 1999:53:303 Cluster headaches Creutzfeldt-Jakob disease cubation period 1 | ’ human 1999:5: nd Brown genetic E200K Cre 1999:5 Cognitive function r y adlaayv eri¢ ri 1 ul 1 e can al) 1999:53:2 irrence of different types o f 1999:53:21 1999:53:2017 Cyclophosphamide pulse cyclophospl 1 é ) il) (Letter); (Good eta Rneeyp Cysticercosis D Dancing mania relicotf sda r gi I I Processiono f Echternacl Krach His ’ lo 1999:53:2169 Deafness neuroimag \ i | ominant cerebel deaft ind narcolepsy (Melberg et al) 1999;5 Death and dying. See a Mortality end-ot fe care: a Irv ri I knowledge (Car ‘ Degenerative disorders ul V 1 ca l ) I diagnosiso f 1999;53:1292 1es In human brain and 1999:5 al) 1999:53:1570 g aspects of corticobasal 199: iclear palsy (Soliveri et al opa tation of cortical-basal ganglionic 1999-53:1969 familial multisysten i tion with parkinsonism associated with the 11778 mitochondrial DNA mutation (Simon et al) 1999;53:1787 frontotemporal lobar degener: n: a conson eclinnicasl duiagsnost ic I Reply) 1999;53:1159 high prevalence of neurovascular instability in neurodegenerative dementias (Idiaquez and Sandoval) (Letter) 1999;53:1610 December (1 of 1) 1999 mutation in the microtu mellitus and the risk of dementia: The Rotterdam Study (Ott luysian degeneration (Y 1999:53:1937 neurodegenerative disea dose reductase inhibition on nerve conduction and 1999;53:411 ometry in diabetic neuropathy (Greene et al) 1999;53:2 580 pat hologic ' 1eterogen¢ sculitis and ischemia in diabetic lumbosacral radiculoplexus degeneration (Boeve pathy (Dyck et al) 1999;53:2113 study of five candidate ¢ etic third nerve palsies are peripheral (Thémke et al) neurodegenerati 1 tter); (Keane and Ahmadi) (Reply) 1999;53:894 Wallerian degenerati f oacetate rehabilitation tcon et ite stabilizes the mutant Ela subunit in pyruvate Reply) 1999;53:1 genase deficiency (Morten et al) 1999;53:612 Dementia. See a/so Alzheimer’s accuracy of four clinic nd, placebo-controlled trial of diclofenac/misoprostol in neurodegenerative dem« mer’s disease (Scharfe t al) 1999;53:197 characterization of risk n mapping Asia Aging Study (R apping applied to mesial temporal lobe epilepsy clinical and quantitati nary observations (Hugg et al) 1999;53:173 bodies (Gomez-Torto clinicopathologic corré yotrophic diplegia: a slowly progressive motor neuron comparison zne rder (Katz et al) 1999;53:1071 dementia as the most degeneration (Gr | study of cerebral glucose metabolism, MRI, and disability diabetes and dementia nts with MS (Blinkenberg et al) 1999;53:149 dama (Li sto ilibrium diabetes mellitus and t gy in older people with disequilibrium of unknown cause et al) 1999;53:19 nan et al) 1999;53:375 differentiationo f vas¢ tests (Looi and Sacl ominant progressive external ophthalmoplegia effect of APOE on der tion of multiple mitochondrial DNA deletions (Moslemi et Rotterdam Study 199:53:79 sis of Huntington’s disease: five years of experience in Rotterdam Austria, and Switzerland (Laccone et al) 1999;53:801 highly active antiz iltisystem degeneration with parkinsonism associated with ibnormalities 778 mitochondrial DNA mutation (Simon et al) 1999;53:1787 high prevalence : lementiasa (I diaqu pterin and tyrosine hydroxylase protein reduction in dopa mortality in elderly e dystonia (Furukawa et al) 1999;53:1032 follow up stb f frontal somatosensory evoked potentials: relation to L- prevalence and s¢ sma levels and motor performance (Ulivelli et al) 1999;53 centenarians randomized trial naan gsc tee pamine concentrations during levodopa treatment regiona! cerebral Di x et al) (Letter) (Contin et al) (Reply) 1999;53:1374 bodies and AD (Is! sonists reorient visual exploration away from the neglected relevance of glutan e (Barrett) (Letter); (Geminiani) (Letter); (Grujic) (Reply) associated deme! report of the second 1610 REY aR es D. receptor gene polymorphism and the risk of levodopa- m9 902 1 dyskinesias in PD (Oliveri et al) 1999;53:1425 sex differences in yndrome vs : ; d And1ae¢ rsenCl l © et i | , notype. and gender effects on Alzheimer’sa ne diials ease in 100 vValaidlitly iOaFof i Clli<tin iyca l th Down syndrome (Lai et al) 1999;53:331 bodies (Verghese et ' ; ; B Demyea lniabns atéi ng. £ di: sorders.2 S 99-o5l 3:~5 9r2i pheral neuropathy : in inNj ection drug8 users (berg8e r et diagnostic value of myot —— polyneuropath . Gl1iaaPoNnnosOtsivcl t vaaliuue ) ra »f Creutzfeldt-Jakob disease with cadaveric dura demvelinatins plantation in Japan (Nakamura et al) 1999;53:218 interferon-61 Kuntzer et ) juring basilar artery balloon occlusion (Hartmann et al) matrix metaillopr treatment (Kiesei : mat« ridxe m.v emli eitnaaltlion‘ pg|r ot‘ eip©r S rapihiban orm(aLleivyt ieest adle) te1c9t9e9d; 5r3bay : 63>< 9‘ H-MRS in dy4 scalculia and neuropathy (Lepper p) ulse cyclopphh osphamamiidd e s a surface membrane-associated pord otein that is absent in et al) (Reply) 1999;53 shi myopathy (Matsuda et al) 1999;53:1119 quantitative MRI in . suggestive of den bnormalities detected by ‘H-MRS in dyscalculia and 1999:53:1893 phia (Levy et al) 1999;53:639 randomized trial of interf 1esia demyelinating polyrad e D, receptor gene polymorphism and the risk of levodopa- Depression ed dyskinesias in PD (Oliveri et al) 1999;53:1425 co-morbid psychiatric dis¢ pine treats resting tremor, essential tremor, and levodopa- etiology of depression F ed dyskinesias (Pact and Giduz) 1999;53:1154 depressive disorders 1999:53:S26 rphometry in reading-disabled twins (Pennington et al) 1999; postexercise motor evok¢ depressed patients, an nfrasylvian surface in dyslexia: novel magnetic resonance Devic’s syndrome ng-based findings (Green et al) 1999;53:974 clinical course of neuror et al) 1999-:53:1107 perception of vibration-induced illusion of movement in MRI and magnetization t1 tonia (Rome and Griinewald) 1999;53:1794 neuromyelitis optica (1 num toxin A in patients with oromandibular dystonia: long term Diabetes mellitus w-up (Tan et al) 1999;53:2102 diabetes and dementi: é pallidus deep brain stimulation for generalized dystonia: damage? (Lovestone) (Ed and PET investigation (Kumar et al) 1999;53:871 December (1 of 1) 1999 NEUROLOGY 53 2223 contribution to psychopathology 1999;53:549 epilepsy: recogn tion ana Sept supp! 2) 1999;53:S3 in generalized epilepsy ne for th atment f Markowitz « Economics ocloni 1999:5 encepha Education Medical education Elderly persons Geriatric population Electroencephalography »3:926 ectropl! VS1O Encephalitis Epley’s procedure | é t pha Estradiol Ence ph ilopathy Europe 1999:53:S Evoked pote ntials Endolymphati« sac tumors Enteroviruses Enzyme-linked immunosorbent assay GM1 ft eyelid open { et 1999:53:2206 ‘ } et " 1999-5 , 1} } Editorial) 1999-5 Epilepsy Antiepileptic drugs; Temporal lobe epi lepsy | D I Sept Familial hemiplegic migraine CACNAIA mutations: hemipleg graine, episodic ataxia Editorial) 1999;53:3 ith familial hemiplegi I mi ( izolamide-responsive familial I graine al t tini et al) 1999;53 38 December (1 of 1) 1999 Fatigue e 17p-linked myasthenias stem from defects in the absence of Borr ‘ oline receptor e-subunit gene (Middleton et al) latigue syna! 1076 enhanced fatig if ALS patients in central Italy due to the occurrence of the Friedman SOD1 gene mutation (Ceroni et al) 1999:53:1064 med n the gyral pattern distinguish chromosome 17-linked and 1648 issencephaly (Dobyns et al) 1999;53:270 quantitative ass e autosomal dominant vacuolar neuromyopathy linked to et al) 1999;53:7 Servidei et al) 1999;53:830 Ferroxidases of Huntington’s disease: five years of experience in radical reactions Austria, and Switzerland (Laccone et al) 1999;53:801 ferroxidast D receptor gene polymorphism and the risk of levodopa Editoria yskinesias in PD (Oliveri et al) 1999;53:1425 Finnish population the gene frequency of aceruloplasminemia in Japan founder mutation ma et al) 1 53:617 northert the GluR6 gene associated with younger onset age of Flumazenil yn’s disease (MacDonald et al) 1999;53:} 1330 glucose ind isystem degeneration with parkinsonism associated with 8 mitochondrial DNA mutation (Simon et al) 1999:53:1787 ition of a new locus for recessive familial spastic : ; resis to 15q13-15 (Martinez Murillo et al) 1999;53:50 Fornix ition of the familial adult myoclonic epilepsy (FAME quantitatir Rl t romosome 8q24 (Plaster et al) 1999;53:1180 disease with a PrP P105L mutation: clinicopathologic eterogeneity (Yamada et al) 1999;53:181 tosomal dominant progressive external ophthalmoplegia ritical region on 10q24 (Li et al) 1999;53:1265 $04 sease in Italian monozygotic twins (Andreone et al) 1999 French, Joseph H. eph H. Fre ilysis of the tau gene in progressive supranuclear palsy 3:1168 al) 1999;53:1421 French population CHRNA4 responsible for autosomal dominant frontal lobe Hirose et al) 1999:53:1749 paction in Charcot-Marie-Tooth neuropathy type 1A with ition of peripheral myelin protein-22 (Fabrizi et al based coho 346 Friedrich ataxia rvlase gene transfer in McArdle’s disease myoblasts in t 1999:53:1352 . “yep %y..cagugens ve diseases of Guam: analysiso f TAU (Pérez-Tur et al Frontal lobes 11) \POE-€4 is A t between Gl‘ u/Aso pol} ymorphism of NOS3 gene and ische MacLeod et al) 1999;53:418 if alpha-2 macroglobulin gene five-nucleotide deletion n Taiwan Chinese (Hu et al) 1999;53:642 of paraoxonase gene polymorphism with atherosclerosis s disease (Sodeyama et al) 1999;53:1146 F — GAAGGA repeat in the Friedrich gene: implications for Frontotemporal lobe Ohshima et al) ' 1999;53:1854 3 ease in twins: a follow-up study (Vieregge et al) 1999 I t | G «hemical studies of juvenile parkinsonism linked t¢ ‘ 6q (Rajput) (Letter); (Mori) (Reply) 1999;53:1375 Gabapentin parkinsonism associated with mutation in the a ibapent ne (Samieti a l) 1999;53:2097 Gangliosides is of autosomal dominant hereditary spastic B iked to chromosome 8q (Hedera et al) 1999;53:44 enetic diagnosis for spinal muscular atrophy type 1 1999:53:1087 dence for anticipation in genetic E200K Creutzfeldt Gastrostomy se (Rosenmann et al) 1999:53:1328 tion of a TNF gene polymorphism with susceptibility to erosis (Fernandez-Arquero et al) 1999;53:1361 Gender. Se Sex; Women and environmental factors in migraine without APOE genot 999:53:995 ing in anticipation (Ashizawa and end liffers Editorial) 1999;53:1164 if patient tion in a patient with slowly progressing familial ALS Gene therapy 1999:53:404 el t ( ndidate genes in Parkinson’s disease and related Sanols S erative disorders (Nicholl et al) 1999;53:1415 Genetics. Se Apolipoprotein I ation in an endolymphatic sac tumor associated with ndau disease (Kaw: ahara et al) 1999;53:208 lau disease: how does one gene cause multiple tumors? Ed il) 1999:53:7 population 1999:5 1 individuals with high blood pressure: a osomal domin study in the elderly (Tzourio et al) 1999;53:1948 tional n older people with disequilibrium of unknown caus« reces ‘ t al 1999:53:375 severity of dementia among northern Italian ns (Ravaglia et al) 1999;53:416 In size is related to low Mini-Mental State Examination Andersor community sample of nondemented older adults candidatet genes and 1 s et al) 1999:53:228 m gliomas (Chamberlain) (Letter); (De Angelis and Reply) 1999;53:437 December (1 of 1) 1999 NEUROLOGY 53 r l « incement in a patient with seizures and previously pontine anosognosia for hemiplegia (Evyapan and Kumral) 1999;53 ected gli ise of MRS (Quan et al) 1999;53:211 647 Globus pallidus Hemodynamics t | stimulationfo r generalized dystonia brain arteriosclerosis and hemodynamic disturbance may induce Kum t al) 1999:53 leukoaraiosis (Yamauchi « 1) 1999:53:1833 Glucose cerebral hemodynamic impairment: methods of measurement and ibnormal ies of thalamic association with stroke risk (Derdeyn et al) (Views & Reviews 1999;53:2037 1999-:53:251 tabolism, MRI, and disability Hemorrhage. See a/so Intracerebral hemorrhage 1999:53:149 aneurysms in relatives of patients with subarachnoid hemorrhage Glutamate frequency and risk factors (Raaymakers and the MARS Study H-MRS 1 f rodegeneration al ess glutamate Group) 1999:53:982 53:71 rebellar hemorrhage presentin as orthostatic headache: two case ients with HIV-1 reports (Chen et al) 1999;53:1887 1999:5 rebral amyloid angiopathy with unilateral hemorrhages, mass effect Glutamine and meningeal enhancement (Morton-Bours et al) 1999;53:233 ajor bleeding during anticoagulation after cerebral ischemia patterns and ri factors (Gorter) 1999;53:1319 Guam MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy (Greenberg et al) 1999;53:1135 ptosis, blepharospasm, and apraxia of eyelid opening secondary to Guillain-Barré syndrome putaminal hemorrhage (Verghese et al) 1999;53:65 Hepatitis encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? (Tourbahet al) 1999;53:396 neurologic complications associated with hepatitis C virus infection intibodies transmitted Temb! et al) 1999;53:861 1999:53:1246 Heroin iter intravenous leukoencephalopathy and ra 1 brain lactate from heroin vapor il) 1999:53:598 inhalation (“chasing t lragon Kriegstein et al) 1999;53:1765 rs after Guillair Herpesviruses absence of ht herpesvirus 6 and 7 from spinal fluid and serum of 4 multiple sclerosis patients (Mirandola et al) 1999;53:1367 9 136 Hippocampus Gustatory function cognitive consequences of coexisting temporal lobe developmental 1 M pontine les malformations and hippo sclerosis (Martin et al) 1999;53 H Lette I ika eta I 1999:53:1160 709 Gynecomastia cognitive correlates of 'H MRSI detected hippocampal abnormalities in ir atropny temporal lobe epilepsy ‘Martin et al) 1999;53:2052 MRI volumes of amygdala and hippocampus in non-mentally retarded 1999:53:435 autistic adolescents and adults (Aylward et al) 1999;53:2145 Gypsy population Human growth hormone ncubation period of Creutz Jakob disease in human growth hormone recipients France (d’Aignauxe t al) 1999 1197 Human immunodeficiency virus distinct light microscopic changes in HIV sociated nemaline H myopathy (Mir6 et al) (Letter); (Feinberg et al) (Reply) 1999;53:241 Haloperidol loes HIV-8 have a protective role on the deve lopment of HIV i operidol for beha encephalopathy? (Dorruccie t al) 1999;53:2032 1999-53 ghly active antiretroviral therapy reverses brain metabolite Hamartomas abnormalities in mild HIV dementia (Chang et al) 1999;53 prevalence of peripheral neuropat injection drug users (B , 1999-53:2237 il) 1999:53:592 Headache. S Cluster headaches; Familial hemiplegic randomized trial of t pla tivating factor antagonist lexipafant migraine; Menstrual migraine; Migraine in HIV-associate mpairment (Schifittoe t al) 1999;53 resenting as orthostatic headache 391 * of patients with HIV-1 workplace issociated dementia comp! E y et al) 1999;53:1144 Human leukocyte antigens HLA DQ1 associated with reflex sympathetic dystrophy (Kemler et al 1999:53:1350 Human T-cell lymphotrophic virus type 1 inverse correlation of HTLV-1 viral load in CSF and intrathecal Head size esis of HTLV-1 antibodies in TSP/HAM (Puccioni-Sohler et monozygotic twins al) 1999:53:1335 Reply) 1999;53:242 quantitative assessment of subclinical spasticity in human T-cell Examination lymphotrophic virus type 1 infection (Zunt et al) 1999;53:386 adults Huntington’s disease clinical correlation of striatal ‘H MRS changes in Huntington’s disease Health care Sanchez-Pernaute et al) 1999;53:806 Stolp DNA analysis of Huntington’s disease: five years of experience in Germany, Austria, and Switzerland (Lacconeet al) 1999;53:801 Heart evidence for the GluR6 gene associated with younger onset age of Huntington's disease (MacDonald et al) 1999:53:1330 influence of lamotrigine on progression of early Huntington diseasé Heart rate randomized clinical trial (Kremer et al) 1999;53:1000 long-lasting improvement following OSU6162 in a patient with Huntington’s disease (Tedroff et al) 1999;53:1605 Hemicrania Hyperalgesia headache but not in chronic brain processing of capsaicin-induced secondary hyperalgesia: a ’ é ini ey t al) 1999:53:357 functional MRI study (Baron et al) 1999;53:548 Hemifacial spasm Hyperornithinemia é ntrolled MRI/MRAs t irovascular contact in hemi reduced brain creatine in gyrate atrophy of the choroid and retina with Ho et al) 1999:53:2133 hyperornithinemia (Nanté-Salonen) 1999;53:303 Hemiplegia. S: Familial hemiplegic migraine Hypertension. See also Intracranial hypertension itation in CACNAIA causes episodic ataxia and cognitive decline in individuals with high blood pressure ‘ " 1 et al) 1999:53:34 longitudinal study in the elderly (Tzourio et al) 1999;5¢ ROLOGY 53 December (1 of 1) 1999